Humedix to Sign an Exclusive Sales Agreement for Reedle Booster for Hospitals and Clinics

신민준 2025. 8. 11. 14:26
자동요약 기사 제목과 주요 문장을 기반으로 자동요약한 결과입니다.
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.

Evov Therapeutics CEO Park Byung kook said "Through our partnership with Humedix which has established a strong foothold in aesthetics market in Korea Evov Therapeutics plans to promote the technological prowess of Reedle Booster and maximize its brand value."

Humedix CEO Kang Min jong said "Reedle Booster is a professional product that started from the brand awareness and consumer needs of the Reedle Shot that has already achieved great success in K-beauty market. We have strengthened our product portfolio with new additions such as this treatment solution targeting the epidermis layer differentiated from our existing product line."

음성재생 설정 이동 통신망에서 음성 재생 시 데이터 요금이 발생할 수 있습니다. 글자 수 10,000자 초과 시 일부만 음성으로 제공합니다.
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

[Shin-Min Joon, Edaily Reporter] Humedix of Huons Group strengthened its aesthetics portfolio by securing commercialization rights for Reedle Booster in Korea.

Humedix has signed an exclusive sales agreement for ‘Reedle Booster’ with Evov Therapeutics on August 8. From the left, Humedix CEO Kang Min-jong and Evov Therapeutics CEO Park Byung kook pose for a photo during a signing ceremony for an exclusive sales agreement. (image=Humedix)
Humedix Co. Ltd. announced on August 11 that it has signed an exclusive commercialization agreement for Reedle Booster with Evov Therapeutics Co. Ltd.

The Reedle Booster co developed by VT Cosmetics (hereafter VT) and Evov Therapeutics, is an exclusive product made for use in hospitals and clinics, leveraging the popularity of VT’s Reedle Shot in the global aesthetics market. Compared to injectable skin booster treatments, Reedle Booster procedure offers minimal pain and a shorter recovery time, allowing for a faster return to daily life after the treatment. It also provides immediate improvement in skin vitality.

With VT’s proprietary RED REEDLE™ channeling technology Reedle Booster creates micro-channels on the skin surface, facilitating delivery of active ingredients deep into the dermal layer.

Through this agreement Humedix has secured the exclusive commercialization rights in Korea for Reedle Booster EX and Reedle Booster PN, which contain next generation plant derived exosomes and small molecule polynucleotides (PN) as their respective active ingredients. Humedix plans to expand its presence in the aesthetics market by focusing on distribution to hospitals and clinics specializing in aesthetics including dermatology and plastic surgery.

Evov Therapeutics CEO Park Byung kook said “Through our partnership with Humedix which has established a strong foothold in aesthetics market in Korea Evov Therapeutics plans to promote the technological prowess of Reedle Booster and maximize its brand value.”

Humedix CEO Kang Min jong said “Reedle Booster is a professional product that started from the brand awareness and consumer needs of the Reedle Shot that has already achieved great success in K-beauty market. We have strengthened our product portfolio with new additions such as this treatment solution targeting the epidermis layer differentiated from our existing product line.”

신민준 (adonis@edaily.co.kr)

Copyright © 이데일리. 무단전재 및 재배포 금지.